A Day Up For Cyclacel Pharmaceuticals, Inc.
Mon 20 Apr 20 at 05:30 PM
Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ) shot up at $8.64, representing a gain of 34.8%. The stock appeared on our News Catalysts scanner on Mon 20 Apr 20 at 11:01 AM in the 'PATNERSHIP' category. From Fri 03 Apr 20, the stock recorded 44.44% Up Days and 20.00% Green Days
About Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ)
Cyclacel Pharmaceuticals Inc is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, mechanism-targeted drugs to treat cancer and other serious disorders, with development operations in US and UK.
Top 10 Gainers:
- Benitec Biopharma Limited (BNTC:NASDAQ), 124.01%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 69.74%
- Immuron Limited (IMRN:NASDAQ), 36.17%
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 34.79%
- Corts Trust for J.C. Penney Debentures (KTP:NYSE), 34.48%
- CABCO Trust for JC Penney Debentures (PFH:NYSE), 34.3%
- The Peck Company Holdings, Inc. (PECK:NASDAQ), 33.5%
- Golar LNG Partners LP (GMLP:NASDAQ), 32.61%
- GasLog Ltd. (GLOG:NYSE), 29.35%
- Vericity, Inc. (VERY:NASDAQ), 27.33%